Fusen Pharmaceutical Company Limited

SEHK:1652 株式レポート

時価総額:HK$665.4m

Fusen Pharmaceutical バランスシートの健全性

財務の健全性 基準チェック /16

Fusen Pharmaceuticalの総株主資本はCN¥519.2M 、総負債はCN¥347.9Mで、負債比率は67%となります。総資産と総負債はそれぞれCN¥1.3BとCN¥818.2Mです。

主要情報

67.0%

負債資本比率

CN¥347.94m

負債

インタレスト・カバレッジ・レシオn/a
現金CN¥2.82m
エクイティCN¥519.16m
負債合計CN¥818.21m
総資産CN¥1.34b

財務の健全性に関する最新情報

Recent updates

Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky

May 21
Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky

Fusen Pharmaceutical Company Limited's (HKG:1652) Popularity With Investors Under Threat As Stock Sinks 27%

Mar 31
Fusen Pharmaceutical Company Limited's (HKG:1652) Popularity With Investors Under Threat As Stock Sinks 27%

Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky

Dec 14
Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky

Here's Why Fusen Pharmaceutical (HKG:1652) Can Manage Its Debt Responsibly

Sep 02
Here's Why Fusen Pharmaceutical (HKG:1652) Can Manage Its Debt Responsibly

Fusen Pharmaceutical (HKG:1652) Seems To Use Debt Quite Sensibly

Apr 02
Fusen Pharmaceutical (HKG:1652) Seems To Use Debt Quite Sensibly

A Look At Fusen Pharmaceutical's (HKG:1652) Share Price Returns

Mar 06
A Look At Fusen Pharmaceutical's (HKG:1652) Share Price Returns

We Wouldn't Rely On Fusen Pharmaceutical's (HKG:1652) Statutory Earnings As A Guide

Feb 08
We Wouldn't Rely On Fusen Pharmaceutical's (HKG:1652) Statutory Earnings As A Guide

Is Fusen Pharmaceutical Company Limited's (HKG:1652) Recent Price Movement Underpinned By Its Weak Fundamentals?

Jan 18
Is Fusen Pharmaceutical Company Limited's (HKG:1652) Recent Price Movement Underpinned By Its Weak Fundamentals?

Does Fusen Pharmaceutical (HKG:1652) Have A Healthy Balance Sheet?

Dec 28
Does Fusen Pharmaceutical (HKG:1652) Have A Healthy Balance Sheet?

What You Need To Know About Fusen Pharmaceutical Company Limited's (HKG:1652) Investor Composition

Dec 07
What You Need To Know About Fusen Pharmaceutical Company Limited's (HKG:1652) Investor Composition

If You Had Bought Fusen Pharmaceutical (HKG:1652) Shares A Year Ago You'd Have Earned 34% Returns

Nov 20
If You Had Bought Fusen Pharmaceutical (HKG:1652) Shares A Year Ago You'd Have Earned 34% Returns

財務状況分析

短期負債: 1652の 短期資産 ( CN¥504.2M ) は 短期負債 ( CN¥690.8M ) をカバーしていません。

長期負債: 1652の短期資産 ( CN¥504.2M ) が 長期負債 ( CN¥127.4M ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: 1652の 純負債対資本比率 ( 66.5% ) は 高い と見なされます。

負債の削減: 1652の負債対資本比率は、過去 5 年間で26.6%から67%に増加しました。

債務返済能力: 1652の 営業キャッシュフロー はマイナスであるため、負債は十分にカバーされていません。

インタレストカバレッジ: 1652の負債に対する 利息支払いEBIT によって 十分にカバーされている かどうかを判断するにはデータが不十分です。


貸借対照表


健全な企業の発掘